(Q42598553)

3 November 2017

In vitro antibacterial activity of the ceftazidime-avibactam (NXL104) combination against Pseudomonas aeruginosa clinical isolates (English)

1 reference

3 November 2017

Pseudomonas aeruginosa

0 references

author name string

Premavathy Levasseur

1

1 reference

3 November 2017

Anne-Marie Girard

2

1 reference

3 November 2017

Monique Claudon

3

1 reference

3 November 2017

Herman Goossens

4

1 reference

3 November 2017

Michael T Black

5

1 reference

3 November 2017

Kenneth Coleman

6

1 reference

3 November 2017

Christine Miossec

7

1 reference

3 November 2017

language of work or name

English

0 references

publication date

3 January 2012

1 reference

Antimicrobial Agents and Chemotherapy

3 November 2017

1 reference

3 November 2017

56

1 reference

3 November 2017

3

1 reference

3 November 2017

1606-1608

1 reference

In vitro activity of ceftazidime combined with NXL104 versus Pseudomonas aeruginosa isolates obtained from patients in Canadian hospitals (CANWARD 2009 study).

3 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294935

In vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermenters

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294935

Impact of multidrug-resistant Pseudomonas aeruginosa bacteremia on patient outcomes.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294935

Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294935

In vitro activity of the {beta}-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294935

Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294935

Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294935

Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294935

In vitro activity of AVE1330A, an innovative broad-spectrum non-beta-lactam beta-lactamase inhibitor

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3294935

16 August 2018

Identifiers

DOI

10.1128/AAC.06064-11

1 reference

3 November 2017

1 reference

3 November 2017

PubMed publication ID

22214778

1 reference